Literature DB >> 18321734

Myoclonic absence epilepsy with photosensitivity and a gain of function mutation in glutamate dehydrogenase.

Nadia Bahi-Buisson1, Sandra El Sabbagh, Christine Soufflet, Fabienne Escande, Nathalie Boddaert, Vassili Valayannopoulos, Christine Bellané-Chantelot, Karine Lascelles, Olivier Dulac, Perrine Plouin, Pascale de Lonlay.   

Abstract

Activating mutations in glutamate dehydrogenase (GDH), de novo or dominantly inherited, are responsible for the hyperinsulinism/hyperammonemia (HI/HA) syndrome. Epilepsy has been frequently reported in association with mutations in GDH, but the epilepsy phenotype has not been clearly determined. Here, we describe a family with a dominantly inherited mutation in GDH. The mother, brother and both sisters had myoclonic absence seizures, but only the mother and one sister had the complete HI/HA pattern. For the two sisters with myoclonic absences, epilepsy started during the second year of life while the brother, it started at 6 years. All 3 children showed the same EEG pattern characterized by photosensitive generalized and irregular spike-wave discharges and runs of multiple spikes. The mother's EEG recordings were normal without photosensitivity. Magnetic resonance imaging (MRI) and spectroscopy (MRS) were normal. A direct effect of the GDH mutation, perhaps in combination with recurrent hypoglycemia and chronic hyperammonemia could provide a pathophysiological explanation for the epilepsy observed in this syndrome and these are discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18321734     DOI: 10.1016/j.seizure.2008.01.005

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  10 in total

Review 1.  Treatable Genetic Metabolic Epilepsies.

Authors:  Lama Assi; Youssef Saklawi; Pascale E Karam; Makram Obeid
Journal:  Curr Treat Options Neurol       Date:  2017-09       Impact factor: 3.598

Review 2.  The hyperinsulinism/hyperammonemia syndrome.

Authors:  Andrew A Palladino; Charles A Stanley
Journal:  Rev Endocr Metab Disord       Date:  2010-09       Impact factor: 6.514

Review 3.  Epilepsy and inborn errors of metabolism in children.

Authors:  N I Wolf; A García-Cazorla; G F Hoffmann
Journal:  J Inherit Metab Dis       Date:  2009-07-31       Impact factor: 4.982

4.  Early Presentation of Hyperinsulinism/Hyperammonemia Syndrome in Three Serbian Patients.

Authors:  Adrijan Sarajlija; Tatjana Milenkovic; Maja Djordjevic; Katarina Mitrovic; Sladjana Todorovic; Bozica Kecman; Khalid Hussain
Journal:  J Clin Res Pediatr Endocrinol       Date:  2015-12-18

5.  De novo variants in SETD1B cause intellectual disability, autism spectrum disorder, and epilepsy with myoclonic absences.

Authors:  Takuya Hiraide; Ayako Hattori; Daisuke Ieda; Ikumi Hori; Shinji Saitoh; Mitsuko Nakashima; Hirotomo Saitsu
Journal:  Epilepsia Open       Date:  2019-05-24

Review 6.  Inborn errors of enzymes in glutamate metabolism.

Authors:  Lynne Rumping; Esmee Vringer; Roderick H J Houwen; Peter M van Hasselt; Judith J M Jans; Nanda M Verhoeven-Duif
Journal:  J Inherit Metab Dis       Date:  2019-10-11       Impact factor: 4.982

Review 7.  Molecular mechanisms of protein induced hyperinsulinaemic hypoglycaemia.

Authors:  Suresh Chandran; Fabian Yap; Khalid Hussain
Journal:  World J Diabetes       Date:  2014-10-15

Review 8.  From Physiology to Pathology of Cortico-Thalamo-Cortical Oscillations: Astroglia as a Target for Further Research.

Authors:  Davide Gobbo; Anja Scheller; Frank Kirchhoff
Journal:  Front Neurol       Date:  2021-06-09       Impact factor: 4.003

9.  Metabolic causes of epileptic encephalopathy.

Authors:  Joe Yuezhou Yu; Phillip L Pearl
Journal:  Epilepsy Res Treat       Date:  2013-05-22

10.  Hyperinsulinism-hyperammonaemia syndrome: novel mutations in the GLUD1 gene and genotype-phenotype correlations.

Authors:  Ritika R Kapoor; Sarah E Flanagan; Piers Fulton; Anupam Chakrapani; Bernadette Chadefaux; Tawfeg Ben-Omran; Indraneel Banerjee; Julian P Shield; Sian Ellard; Khalid Hussain
Journal:  Eur J Endocrinol       Date:  2009-08-18       Impact factor: 6.664

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.